20 May 2026
EU Pharmaceutical Package | Part I – Regulatory Data & Market Protection, Orphan Market Exclusivity, Bolar Exemption and Antimicrobial Vouchers
15 min read
This is our first news alert on the pharmaceutical package, as released in March 2026, addressing four commercially critical areas: (i) regulatory data and market protection; (ii) market exclusivity for orphan medicinal products; (iii) the Bolar exemption; and (iv) the new transferable exclusivity vouchers for priority antimicrobials.
See more via the below note
Attachments:
Key contacts
News & insights
5 min
read
read
Briefings
Urban Wastewater Treatment Directive Remains Focus of Litigation and Parliamentary Activity
15 September 2026
10 min
read
read
Briefings
Belgian Council of State Suspends EUR 750 Million Casino Concession Award on Foreign Subsidies Regulation Grounds: A First for Belgian Public Tendering Litigation
17 September 2026
3 min
read
read
Briefings
Belgian Competition Authority Issues Historic First Decision on Abuse of Economic Dependence
8 September 2026
2 min
read
read
Briefings
Belgium’s Interfederal Screening Committee Issues First-Ever Prohibition of Foreign Direct Investment
10 August 2026
3 min
read
read
Briefings
First Annual Report on Belgian Foreign Direct Investment Screening Published
7 October 2024
1 min
read
read
Briefings
VBB secures lowest anti-dumping duty for Hankook in EU passenger car tyre investigation
7 July 2026
2 min
read
read
Briefings
Lithuanian Competition Authority Fines Pharmacy Association and Individual Firms for Collusion while Participating in Margin-setting Procedure
14 December 2022
